// App-Quantinova.ai

10093 : Long-term cardiovascular outcomes and overall survival of early-stage breast cancer patients with early discontinuation of trastuzumab.

Researchers

Presenter

  • Inna Y Gong

Principal Investigators

  • Sunil Verma

  • Andrew T Yan

  • Dennis T Ko

  • Craig Earle

  • George A. Tomlinson

  • Maureen E. Trudeau

  • Monika K. Krzyzanowska

  • Christine Brezden-Masley

  • Scott Gavura

  • Kelvin K. Chan

Medical Centers

  • University of Toronto, Toronto, ON, Canada

  • Cumming School of Medicine, University of Calgary, Calgary, AB, Canada

  • St. Michael's Hosp, Toronto, ON, Canada

  • Institute of Clinical Evaluative Sciences, Toronto, ON, Canada

  • Ontario Institute for Cancer Research, Toronto, ON, Canada

  • Universtiy Health Network, Toronto, ON, Canada

  • Sunnybrook Health Sciences Centre, Toronto, ON, Canada

  • Princess Margaret Cancer Centre, University Health Network, Division of Medical Oncology and Hematology, Toronto, ON, Canada

  • Department of Medicine, St. Michael's Hospital, Toronto, ON, Canada

  • Cancer Care Ontario, Toronto, ON, Canada

  • Sunnybrook Odette Cancer Centre, University of Toronto, Toronto, ON, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

Disease

  • Breast cancer

  • Myocardial infarction

  • Congestive heart failure

  • Solid malignancies

  • Stroke

Biomarkers

  • N/A

Drug/Treatment

  • Trastuzumab

Outcome

  • Negative

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved